YS-201 is primarily utilized in the field of medical research, particularly in the development of therapeutic agents targeting specific biological pathways. It has shown potential in modulating cellular processes that are crucial in the treatment of certain diseases, including cancer. Researchers are exploring its efficacy in inhibiting the growth of tumor cells by interfering with key signaling mechanisms that promote cell proliferation and survival. Additionally, YS-201 is being studied for its role in enhancing the effectiveness of existing chemotherapeutic drugs, potentially reducing the required dosage and minimizing side effects. Its application extends to preclinical studies where it is used to understand the molecular basis of disease and to identify new targets for drug development.